We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+13.95%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$50.1B
AUM Growth
+$5.82B
Cap. Flow
+$1.21B
Cap. Flow %
2.42%
Top 10 Hldgs %
31.93%
Holding
2,219
New
138
Increased
857
Reduced
1,077
Closed
142

Top Buys

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$166M
2
MSFT icon
Microsoft
MSFT
+$138M
3
NVDA icon
NVIDIA
NVDA
+$132M
4
AAPL icon
Apple
AAPL
+$119M
5
AMZN icon
Amazon
AMZN
+$87.3M

Top Sells

Rank Stock Value
1
GWW icon
W.W. Grainger
GWW
+$155M
2
GS icon
Goldman Sachs
GS
+$119M
3
ED icon
Consolidated Edison
ED
+$47.3M
4
KO icon
Coca-Cola
KO
+$36.3M
5
ATO icon
Atmos Energy
ATO
+$32.6M

Sector Composition

Rank Sector Weight
1 Technology 35.67%
2 Consumer Discretionary 10.36%
3 Industrials 9.42%
4 Communication Services 9.36%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMR icon
2126
Immersion
IMMR
$214M
-25,381
Closed -$192K
INMD icon
2127
InMode
INMD
$889M
-14,209
Closed -$252K
INZY
2128
DELISTED
Inozyme Pharma
INZY
-14,521
Closed -$13.2K
IPSC icon
2129
Century Therapeutics
IPSC
$402M
-10,131
Closed -$4.82K
IVVD icon
2130
Invivyd
IVVD
$205M
-17,168
Closed -$10.4K
JOUT icon
2131
Johnson Outdoors
JOUT
$485M
-261,304
Closed -$6.49M
JWN
2132
DELISTED
Nordstrom
JWN
-16,048
Closed -$392K
KALV
2133
DELISTED
KalVista Pharmaceuticals
KALV
-10,666
Closed -$123K
KNSA icon
2134
Kiniksa Pharmaceuticals
KNSA
$4.86B
-10,225
Closed -$227K
LCTX icon
2135
Lineage Cell Therapeutics
LCTX
$279M
-38,865
Closed -$17.6K
LESL icon
2136
Leslie's
LESL
$24.4M
-2,008
Closed -$29.5K
LNZA icon
2137
LanzaTech
LNZA
$63.9M
-242
Closed -$5.86K
LVO icon
2138
LiveOne
LVO
$71.6M
-1,575
Closed -$11K
LWLG icon
2139
Lightwave Logic
LWLG
$949M
-41,661
Closed -$42.7K
LYEL icon
2140
Lyell Immunopharma
LYEL
$326M
-2,398
Closed -$25.8K
LYRA
2141
DELISTED
LYRA THERAPEUTICS INC
LYRA
-210
Closed -$1.32K
MAN icon
2142
ManpowerGroup
MAN
$2.48B
-504,581
Closed -$29.2M
MGNX icon
2143
MacroGenics
MGNX
$279M
-16,137
Closed -$20.5K
KG
2144
Kestrel Group
KG
$72.4M
-969
Closed -$11.1K
MRSN
2145
DELISTED
Mersana Therapeutics
MRSN
-1,151
Closed -$9.91K
NAUT icon
2146
Nautilus Biotechnolgy
NAUT
$217M
-10,546
Closed -$9.08K
NKTR icon
2147
Nektar Therapeutics
NKTR
$2.23B
-2,576
Closed -$26.3K
NMRA icon
2148
Neumora Therapeutics
NMRA
$304M
-25,738
Closed -$25.7K
NNBR icon
2149
NN Inc
NNBR
$270M
-10,072
Closed -$22.8K
NOTE
2150
DELISTED
FiscalNote
NOTE
-1,334
Closed -$12.9K

Similar funds

ProShare Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, ProShare Advisors held 2,219 positions worth $50.1B, up 13% from $44.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q2 2025 filing shows 138 new, 857 increased, 1,077 reduced and 142 closed positions. Its largest new stake was Shopify: 1,659,028 shares worth $191M. The largest sale was W.W. Grainger, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • ProShare Advisors's largest Q2 2025 buy was Shopify: 1,659,028 shares worth $191M.
  • ProShare Advisors added most to Microsoft in Q2 2025, an estimated $138M increase.
  • ProShare Advisors's biggest Q2 2025 reduction was W.W. Grainger, cutting an estimated $155M.
  • ProShare Advisors fully exited ManpowerGroup in Q2 2025, selling an estimated $29.2M.
  • ProShare Advisors's ten largest holdings make up 32% of its $50.1B portfolio in Q2 2025.
  • ProShare Advisors opened 138 new positions and closed 142 in Q2 2025.
  • ProShare Advisors's portfolio value rose 13% quarter-over-quarter to $50.1B.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.